Company Search:
Advanced Search
Sponsored Links
Pierrel Company Snapshot
Pierrel operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other pharmaceutical manufacturers in Europe: Calliditas Therapeutics AB of SWEDEN (2019 sales of 184.83 million Swedish Kronor [US$20.89 million] of which 100% was Operations), Celon Pharma SA of POLAND (102.25 million Polish New Zlotys [US$26.77 million] ), and Vistin Pharma ASA which is based in NORWAY (227.19 million Norwegian Kroner [US$24.48 million] ).

Sales Analysis. During the year ended December of 2019, sales at Pierrel were 21.34 million Euro (US$25.11 million). This is an increase of 7.1% versus 2018, when the company's sales were 19.93 million Euro. This was the third consecutive year of growth at Pierrel.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Pierrel
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): .15
(Figures in Euros )
1 Week -1.0%   13 Weeks 0.3%  
4 Weeks -8.3%   52 Weeks -12.7%  
Pierrel Key Data:
  Ticker: PRL Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 21,344,000
(Year Ending Jan 2020).
Employees: 305
  Currency: Euros Market Cap: 35,247,716
  Fiscal Yr Ends: December Shares Outstanding: 228,881,275
  Share Type: Aziohi Ordinaire Closely Held Shares: 163,322,812
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.